KSKang Sun
Kang Sun
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Kang Sun has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- David Rosmarin
Indiana University School of Medicine, Indianapolis, USA
3 shared publications - Fiona Kuo
Incyte, Wilmington, Delaware, USA
3 shared publications - Kathleen Butler
Incyte Corporation, Wilmington, USA
3 shared publications - John E. Harris
University of Massachusetts Chan Medical School, Worcester, USA
2 shared publications - Pearl Grimes
Vitiligo and Pigmentation Institute of Southern California, Los Angeles, California, USA
2 shared publications - Alice Bendix Gottlieb
UT Southwestern Medical Center Department of Dermatology Dallas, Texas
1 shared publication
Latest Publications
- Open Access
- 13 September 2023
- Published by Elsevier in JID Innovations
- Vol. 3 (6) , 100230
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream
- 13 September 2023
- Published by Elsevier in JID Innovations
- Vol. 3 (6) , 100230
Open AccessBaseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream
- 1 September 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (3) , AB35
27535 Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: 104-week data from a phase 2 study
- 1 September 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (3) , AB35
27535 Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: 104-week data from a phase 2 study
- 1 May 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (5) , S55
311 Effects of ruxolitinib cream in patients with atopic dermatitis with head and/or neck involvement
- 1 May 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (5) , S55
311 Effects of ruxolitinib cream in patients with atopic dermatitis with head and/or neck involvement